IVIg for TS-HDS and FGFR-3 antibody-positive small-fiber neuropathy: A fading signal for efficacy?
- PMID: 36762497
- DOI: 10.1002/mus.27800
IVIg for TS-HDS and FGFR-3 antibody-positive small-fiber neuropathy: A fading signal for efficacy?
Comment on
-
A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies.Muscle Nerve. 2023 May;67(5):363-370. doi: 10.1002/mus.27745. Epub 2022 Nov 29. Muscle Nerve. 2023. PMID: 36367813 Clinical Trial.
References
REFERENCES
-
- Freeman R, Gewandter JS, Faber CG, et al. Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology. 2020;95:1005-1014.
-
- Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019;142:3728-3736.
-
- Hoeijmakers JGJ, Merkies ISJ, Faber CG. Small fiber neuropathies: expanding their etiologies. Curr Opin Neurol. 2022;35:545-552.
-
- Pindi Sala T, Villedieu M, Damian L, et al. Long-term efficacy of immunoglobulins in small fiber neuropathy related to Sjogren's syndrome. J Neurol. 2020;267:3499-3507.
-
- Gavrilova N, Starshinova A, Zinchenko Y, et al. Small fiber neuropathy in sarcoidosis. Pathophysiology. 2021;28:544-550.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
